CN113498345A - 增强型硝酸盐组合物和使用方法 - Google Patents

增强型硝酸盐组合物和使用方法 Download PDF

Info

Publication number
CN113498345A
CN113498345A CN202080018208.XA CN202080018208A CN113498345A CN 113498345 A CN113498345 A CN 113498345A CN 202080018208 A CN202080018208 A CN 202080018208A CN 113498345 A CN113498345 A CN 113498345A
Authority
CN
China
Prior art keywords
nitrate
elemental
composition
source
elemental metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080018208.XA
Other languages
English (en)
Chinese (zh)
Inventor
A·尼古拉迪斯
R·克雷默
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Semer Life International
Original Assignee
Semer Life International
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Semer Life International filed Critical Semer Life International
Publication of CN113498345A publication Critical patent/CN113498345A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Catalysts (AREA)
CN202080018208.XA 2019-02-01 2020-01-31 增强型硝酸盐组合物和使用方法 Pending CN113498345A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962800361P 2019-02-01 2019-02-01
US62/800,361 2019-02-01
US201962866540P 2019-06-25 2019-06-25
US62/866,540 2019-06-25
PCT/US2020/016274 WO2020160509A1 (en) 2019-02-01 2020-01-31 Enhanced nitrate compositions and methods of use

Publications (1)

Publication Number Publication Date
CN113498345A true CN113498345A (zh) 2021-10-12

Family

ID=71517286

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080018208.XA Pending CN113498345A (zh) 2019-02-01 2020-01-31 增强型硝酸盐组合物和使用方法

Country Status (12)

Country Link
US (5) US20200222449A1 (https=)
EP (1) EP3917543A4 (https=)
JP (1) JP7534310B2 (https=)
KR (1) KR102789451B1 (https=)
CN (1) CN113498345A (https=)
AU (2) AU2020215729B2 (https=)
BR (1) BR112021015110A2 (https=)
CA (1) CA3128232A1 (https=)
EA (1) EA202192132A1 (https=)
IL (1) IL285247A (https=)
MX (1) MX2021009287A (https=)
WO (1) WO2020160509A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8466187B2 (en) 2007-09-18 2013-06-18 Thermolife International, Llc Amino acid compositions
US12612370B2 (en) 2011-03-02 2026-04-28 Thermolife International, Llc Amino acid compositions
WO2022192743A1 (en) * 2021-03-11 2022-09-15 Thermolife International, Llc Enhanced nitrate, elemental metal, and amino acid compositions and methods of use
US11865139B2 (en) 2020-11-12 2024-01-09 Thermolife International, Llc Method of treating migraines and headaches
WO2022174116A1 (en) * 2021-02-11 2022-08-18 Thermolife International, Llc A method of administering nitric oxide gas
JP2024541338A (ja) * 2020-11-12 2024-11-08 サーモライフ インターナショナル， エルエルシー 血中酸素飽和度を増大させる方法
AU2022220004A1 (en) * 2021-02-11 2023-08-17 Thermolife International, Llc A method of administering nitric oxide gas
JP2024508952A (ja) * 2021-03-11 2024-02-28 サーモライフ インターナショナル， エルエルシー ニトレートと単体金属とアミノ酸との増強された組成物ならびに使用方法
CA3226249A1 (en) * 2021-08-16 2023-02-23 Thermolife International, Llc Iron supplement compositions and methods of use thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110123654A1 (en) * 2008-06-06 2011-05-26 Ralf Jaeger Synergistic enhancement of cellular ergogenic nutrient uptake, like creatine or carnitine, with tarragon
US20180133247A1 (en) * 2016-11-15 2018-05-17 Berkeley Nox Limited Novel dietary supplements

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU476799B2 (en) * 1974-02-04 1976-08-05 Carlton And United Breweries Limited Preparation of a water soluble isomerised hop extract
US6703056B2 (en) * 2000-09-29 2004-03-09 The Procter + Gamble Co. Beverage compositions comprising arabinogalactan and defined minerals
US7208170B2 (en) * 2002-09-20 2007-04-24 Petersson Lennart G Powder teat dip germicide, fungicide and skin conditioner
CN100399948C (zh) * 2002-12-06 2008-07-09 协和发酵工业株式会社 含氨基酸的饮料和减少氨基酸苦味的方法
DK2124638T3 (en) 2007-02-26 2017-03-20 Heartbeet Ltd COMPOSITION INCREASING PERFORMANCE AND USING IT
US10646508B1 (en) * 2007-09-18 2020-05-12 Thermolife International, Llc Method of safely administering nitrate dietary supplements and compositions
US7777074B2 (en) 2007-09-18 2010-08-17 Thermolife International, Llc Amino acid compounds
US8303995B1 (en) * 2008-06-13 2012-11-06 Board Of Regents, The University Of Texas System Nitrite formulations and their use as nitric oxide prodrugs
ES2538652T3 (es) 2009-06-16 2015-06-23 Dusan Miljkovic Composiciones y procedimientos para producir un potencial negativo de oxidación-reducción estable en materiales consumibles
JP2014513527A (ja) 2011-04-21 2014-06-05 ネステク ソシエテ アノニム パフォーマンス向上のための栄養組成物並びにその作製及び使用方法
JP6016610B2 (ja) 2012-12-20 2016-10-26 江崎グリコ株式会社 筋肉増量用サプリメント
CA2965441C (en) * 2014-10-22 2020-03-24 Innoveco Australia Pty. Ltd. Process for metal extraction with sorption leaching in wet solids
ES2651717B1 (es) 2016-07-26 2018-11-16 Lara OLLER DUQUE Solución acuosa cristaloide isotónica
WO2020214841A1 (en) * 2019-04-16 2020-10-22 Thermolife International, Llc Hexylamine salts and methods of using hexylamine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110123654A1 (en) * 2008-06-06 2011-05-26 Ralf Jaeger Synergistic enhancement of cellular ergogenic nutrient uptake, like creatine or carnitine, with tarragon
US20180133247A1 (en) * 2016-11-15 2018-05-17 Berkeley Nox Limited Novel dietary supplements

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王换成等: "《自然科学基础知识》", 30 June 2016, 北京邮电大学出版社 *

Also Published As

Publication number Publication date
AU2020215729B2 (en) 2023-03-30
JP2022523513A (ja) 2022-04-25
EP3917543A4 (en) 2022-10-12
KR102789451B1 (ko) 2025-03-31
KR20210119499A (ko) 2021-10-05
US20200222449A1 (en) 2020-07-16
US20240122967A1 (en) 2024-04-18
EA202192132A1 (ru) 2021-10-19
AU2020215729A1 (en) 2021-09-02
AU2023203649B2 (en) 2024-11-14
CA3128232A1 (en) 2020-08-06
WO2020160509A1 (en) 2020-08-06
EP3917543A1 (en) 2021-12-08
US20240122968A1 (en) 2024-04-18
US20240122966A1 (en) 2024-04-18
US20240122969A1 (en) 2024-04-18
MX2021009287A (es) 2021-11-12
AU2023203649A1 (en) 2023-07-06
JP7534310B2 (ja) 2024-08-14
BR112021015110A2 (pt) 2022-01-11
IL285247A (en) 2021-09-30

Similar Documents

Publication Publication Date Title
US20240122969A1 (en) Enhanced nitrate compositions and methods of use
Gonzalez et al. Effects of citrulline supplementation on exercise performance in humans: A review of the current literature
Williams Nutritional ergogenics in athletics
TW201204267A (en) Compositions and beverages comprising nutrients, vitamins, sugars, cysteine, and/or sugar-cysteine products
WO2012013928A1 (en) Compositions
WO2010077878A1 (en) Rapidly dissolving vitamin formulation and methods of using the same
EP3737244A1 (en) Compositions and methods for cholesterol, glucose, and microbiome control
WO2022104157A1 (en) Methods of increasing blood oxygen saturation
WO2009082883A1 (fr) Composition anti-obésité
CN102150854B (zh) 一种对化学性肝损伤有辅助保护作用的保健食品
KR20040014540A (ko) 성욕을 증진시키는 방법 및 조성물
WO2017206026A1 (zh) 提升运动能力的能量组合物
CN105343056A (zh) 一种治疗或预防肥胖型高血压的口服药物组合物及其用途
CN111971065A (zh) 瓜氨酸的组合物
RU2468812C2 (ru) Средство, обладающее адаптогенным, тонизирующим и общеукрепляющим действием, и способ его получения
EA049159B1 (ru) Улучшенный нитратный состав и способы применения
US20250000832A1 (en) Enhanced nitrate, elemental metal, and amino acid compositions and methods of use
Najafi et al. Preparation and pharmaceutical evaluation of ferrous sulfate and ascorbic acid floating matrix tablet for prevention of anemia
CN120753397A (zh) 一种新型营养组合物及其应用
CN115721018A (zh) 一种增强耐力的组合物
TR2023011235A2 (tr) Sprey formda bi̇r takvi̇ye edi̇ci̇ gida formülasyonu
Demir et al. Magnesium citrate: potential and current approaches in pharmacy
AU2020217776A1 (en) Compositions and methods for the treatment of constipation and other ailments of the gastrointestinal system
WO2024223532A1 (en) A dietary supplement combination and use thereof for improving muscle performance
US20180169004A1 (en) Sublingual therapeutic solutions and methods

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination